Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HealthTronics' lithotripter combo:

This article was originally published in Clinica

Executive Summary

HealthTronics has received US FDA 510(k) clearance to market what it claims to be the first kidney and ureteral stone-busting lithotripter to combine both electrohydraulic and electromagnetic therapy delivery in one unit. The firm had previously made only electrohydraulic lithotripsy technology, which represents 50% of the lithotripsy market; electromagnetic technology represents the other 50%. The combination product, the LithoDiamond Ultra, can potentially cut a provider's lithotripsy capital costs in half, the Austin, Texas firm claimed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048715

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel